AviPro-ND-LASOTA 1000 & 5000 DOSES DRINKING WATER

Indications

• Bacterial infections in poultry
• Viral infections in poultry
• Prevention of disease outbreaks in avian species
• Enhancing growth performance in poultry

Dosage

Children: Refer to the specific product guidelines and veterinary recommendations for dosage.

Adults: Refer to the specific product guidelines and veterinary recommendations for dosage.

Mechanism of action

Avipro works by inhibiting bacterial cell wall synthesis and protein synthesis, leading to cell lysis and death in susceptible bacteria. Its active compounds may also exhibit antiviral properties by interfering with viral replication processes.

Pharmacodynamics

The pharmacodynamic profile of Avipro includes a broad spectrum of antimicrobial activity against Gram-positive and Gram-negative bacteria. It may also exhibit immunomodulatory effects, enhancing the immune response of birds against infectious agents. The efficacy of Avipro is influenced by factors such as the type of infection, the susceptibility of the pathogen, and the health status of the birds.

Pharmacokinetics

Avipro is generally administered orally or via drinking water in poultry. It is rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations reached shortly after administration. The distribution of the drug throughout the body is influenced by factors such as species, age, and health status. Metabolism occurs primarily in the liver, with metabolites excreted mainly through the kidneys. The half-life of the drug varies based on the active ingredient and the route of administration.

Pregnancy

Consult a healthcare professional before use, as safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use, as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Acute lymphoblastic leukemia (ALL)
• Acute myeloid leukemia (AML)
• Lymphoblastic lymphoma

Dosage

Children: Refer to specific guidelines as dosing may vary based on protocol and patient response.

Adults: Refer to specific guidelines as dosing may vary based on protocol and patient response.

Mechanism of action

Lasota functions as a recombinant enzyme that catalyzes the hydrolysis of asparagine to aspartic acid and ammonia. This enzymatic reaction reduces the availability of asparagine in the bloodstream, which is crucial for the survival of lymphoid cells. Tumors, particularly lymphoblastic leukemia cells, are unable to synthesize asparagine due to the lack of asparagine synthetase, making them susceptible to this depletion.

Pharmacodynamics

The pharmacodynamic effects of lasota are centered on its ability to induce asparagine depletion, leading to apoptosis in asparagine-dependent neoplastic cells. The effectiveness of lasota is influenced by the concentration of asparagine in the body and the sensitivity of the tumor to asparagine depletion. The therapeutic window is critical, as excessive depletion can lead to adverse effects.

Pharmacokinetics

Lasota has a unique pharmacokinetic profile characterized by a short half-life and variable distribution in the body. It is administered intravenously and is rapidly distributed to tissues. The elimination of lasota primarily occurs through hydrolysis and is influenced by the patient's body weight and the presence of enzymes in the blood. Due to its enzyme nature, it does not have a traditional clearance mechanism related to liver or kidney function, making dosing adjustments less straightforward.

Pregnancy

There is limited data on the use of lasota during pregnancy. Caution is advised, and it should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether lasota is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.